Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 22 Show results per page	View Search Criteria \| Help With Results

Last Modified: 10/5/2007 First Published: 7/22/2005


1.		A Phase I/II Study of Erlotinib and Radiotherapy in Young Patients With Newly Diagnosed Intracranial High-Grade Glioma or Unfavorable Low-Grade Glioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				3 to 25				NCI, Pharmaceutical / Industry				SJCRH-SJHG04 GENENTECH-OSI3160s, NCT00124657


2.		A Phase I/II Study of the Photon Radiosurgery System

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				2 to 32				Other				CNS 0201 NCT00179907


3.		Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				1 to 120				Other				R01 CA 89395-01 Topotecan, Brain Tumors, Intracerebral Clysis, NCT00452959

Last Modified: 1/30/2008 First Published: 11/1/1998


4.		Phase II Study of Antineoplastons A10 and AS2-1 in Children With Low-Grade Astrocytoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				6 months to 17 years				Other				BC-BT-13 NCT00003468

Last Modified: 12/7/2007 First Published: 11/1/1998


5.		Phase II Study of Antineoplastons A10 and AS2-1 in Children With Primary Malignant Brain Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				6 months to 17 years				Other				BC-BT-22 NCT00003476

Last Modified: 12/21/2007 First Published: 10/25/2004


6.		Phase II Study of Lapatinib in Pediatric Patients With Recurrent or Refractory Medulloblastoma, Primitive Neuroectodermal Tumors, High-Grade Glioma, or Ependymoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				21 and under				NCI				PBTC-016 PBTC-016, NCT00095940

Last Modified: 6/4/2008 First Published: 10/7/2005


7.		Phase II Study of Reduced-Field Conformal Radiotherapy in Young Patients With Low-Grade Gliomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				3 to 20				NCI				COG-ACNS0221 ACNS0221, CIRB-05016, NCT00238264


8.		A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				8 months to 25 years				Other				RT1 NCT00187226

Last Modified: 5/9/2008 First Published: 7/23/2006


9.		Phase II Pilot Study of Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Young Patients With Relapsed or Progressive Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				21 and under				Other				DFCI-04343 NCT00357500


10.		Thalidomide and Temozolomide or CPT-11 in Patients With Gliomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Not specified				Other				DM02-595 NCT00412542

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute